Virtus Investment Partners (VRTS) holder files Form 144 to sell 2,959 shares
Rhea-AI Filing Summary
A holder of Virtus Investment Partners, Inc. (VRTS) common stock has filed a notice of intent to sell shares under Rule 144. The filing covers 2,959 common shares to be sold through Merrill Lynch, with an indicated aggregate market value of $486,577, out of 6,754,405 shares outstanding. The approximate sale date is listed as December 11, 2025 on the NYSE. The securities were originally acquired as restricted stock granted in lieu of services on several dates between 2013 and 2024, with individual grants ranging from 38 to 637 shares.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for VRTS disclose?
The Form 144 filing for Virtus Investment Partners, Inc. (VRTS) discloses a shareholder’s intent to sell 2,959 common shares of the company under Rule 144.
How many VRTS shares are planned to be sold and what is their market value?
The filing states that 2,959 common shares are to be sold, with an aggregate market value of $486,577, as indicated in the notice.
Through which broker and exchange will the VRTS shares be sold?
The shares are to be sold through Merrill Lynch, with the securities listed for sale on the NYSE, as shown in the filing.
What is the approximate date of sale for the VRTS shares in this Form 144?
The notice lists an approximate sale date of December 11, 2025 for the 2,959 common shares covered by the filing.
How were the VRTS shares in this Form 144 originally acquired?
The securities were acquired as restricted common stock granted in lieu of services on multiple dates, including May 22, 2013, May 20, 2014, May 14, 2021, May 18, 2022, May 17, 2023, and May 15, 2024.
How many VRTS shares are outstanding according to this notice?
The Form 144 indicates that there are 6,754,405 common shares outstanding for Virtus Investment Partners, Inc. at the time referenced.
What representation does the selling holder make in the VRTS Form 144?
By signing the notice, the selling holder represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.